Top 10 Life Science VC (Venture Capital) Funds in Hong Kong in July 2025
A list of 10 VC (Venture Capital) funds that invest in Life science startups based in Hong kong. We rank investors based on the number of investments they made in Life science companies from Hong kong. We update this investor list every month.Top 10 Life Science VC (Venture Capital) Funds in Hong Kong in July 2025
Investor | Life Science Hong Kong investments |
---|---|
Alibaba Entrepreneurs Fund | 2 |
Tiger Jade Capital | 1 |
Vectr | 1 |
AEF Greater Bay Area Fund | 1 |
Hillhouse Ventures | 1 |
Proxima Ventures Ltd | 1 |
Gobi Partners | 1 |
Hillhouse Investment | 1 |
Prox Ventures | 1 |
Alon Capital Ltd | 1 |
The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.
Show more
Investment focus
- Software, E-Commerce, Artificial Intelligence
- Series A, Seed, Series B
- Hong Kong, Taiwan, United States
Portfolio highlights
- Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
- Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
- Rice Robotics Limited — The friendliest robot at your service.
Tiger Jade Capital is a Private Equity fund focused on global healthcare industry. It is a comprehensive healthcare fund covering new drugs, CRO, medical equipment, etc.
Show more
Investment focus
- Biopharma, Life Science, Biotechnology
- Series A
- Hong Kong
Portfolio highlights
- Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.
Show more
Investment focus
- FinTech, Financial Services, Artificial Intelligence
- Seed, Series A, Pre-Seed
- United States, Hong Kong, Singapore
Portfolio highlights
- Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
- Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
- MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
AEF Greater Bay Area Fund is an investment fund.
Show more
Investment focus
- Biotechnology, Sports, Sustainability
- Seed, Series A, Series B
- Hong Kong, China, Macao
Portfolio highlights
- ORCA-TECH — ORCA-TECH is a manufacturer of self-driving boat.
- SleekFlow — SleekFlow makes customer messaging apps such as WhatsApp and Facebook connected to one platform for teams to better support and engage customers.
- Scolioscan — Scolioscan focuses on medical imaging technology research & development, self-service production and technology distribution and promotion.
Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.
Show more
Investment focus
- Manufacturing, Biotechnology, Health Care
- Series A, Series B, Seed
- China, Singapore, Norway
Portfolio highlights
- TARS — Zhihang Zhong is a prominent researcher in the field of artificial intelligence, particularly known for his work on integrating spatial perception and reasoning into AI systems.
- Xinyanyi Code — Xinyanyi Code is an artificial intelligence programming application service provider that focuses on AI Coding and benchmarks the American intelligent code generation product Cursor.
- Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
Proxima Ventures is focused on the management of investment portfolios for its customers. It offers them with financial products and consulting services.
Proxima Ventures was acquired by Soluto in October 2013.
Proxima Ventures was founded by Chaim Venezia and Uri Ra'anan and is based in Tel Aviv, Israel.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- China, United States, Israel
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- Yidianling — Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.
- Immune-Onc Therapeutics — Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
Gobi Partners: Leading Venture Capital in Asia. Accelerating Innovation, Fueling Success.
Show more
Investment focus
- Financial Services, E-Commerce, Internet
- Series A, Seed, Series B
- China, Malaysia, Singapore
Portfolio highlights
- RushOwl — RushOwl is a dynamic ride-sharing company that offers timely and affordable shuttle rides.
- ChaZence — ChaZence is an environmental consulting and biotechnology company that manufactures, innovates, and designs naturally degradable materials for a sustainable lifestyle.
- SkyeChip — Your Preferred cutting edge IP & IC Design solutions for artificial intelligence and high-performance computing.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Series B, Series A, Series C
- China, United States, Singapore
Portfolio highlights
- dinii — Dinii is a mobile order platform for take-out shops.
- Ascentium — At Ascentium, we believe in the power of partnership to realise unlimited growth potential.
- Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
- Medical, Biotechnology, Health Care
- Seed, Funding Round, Series A
- China, United States, United Kingdom
Portfolio highlights
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
- Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
- Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Make the right startup move by using our startup tools, guides, calculators and templates. Learn from other successful entrepreneurs by reading our case studies
Show more
Investment focus
- Biopharma, Life Science, Biotechnology
- Series A
- Hong Kong
Portfolio highlights
- Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Investors by industry
Consumer
Proptech
Impact
Climate
Gaming
Biotech
FinTech
Marketplace
Community
Health Care
Hardware
Energy
Artificial intelligence
Google
EdTech
Sustainability
Venture Capital
Real Estate
Photography
Clean Energy
Education
B2B
Financial Services
Big Data
Payments
Finance
Organic Food
Food and Beverage
Web3
Infrastructure
Retail
Beauty
Publishing
Video Games
Music
Art
Wellness
Franchise
Mobile
Local
Digital Media
Legal
Android
eSports
Enterprise Software
Sports
Manufacturing
Email
Medical
Social Network
Social Media
Internet
Construction
Hospitality
Platforms
Biotechnology
Cannabis
Mobile Advertising
Travel
Fitness
Recruiting
Crowdfunding
Social
Medical Device
Automotive
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Theatre
Film
Non Profit
Sporting Goods
Renewable Energy
SaaS
Celebrity
Restaurants
Social Impact
Software
Machine Learning
Cryptocurrency
Facebook
Agriculture (agtech)
Media (entertainment)
Blockchain
Investors by country
Canada
Germany
United Kingdom
Ireland
South Korea
India
Australia
New Zealand
United States
Middle East
Brazil
LATAM
Qatar
Indonesia
Asia
Europe
Spain
South Africa
Singapore
Armenia
Saudi Arabia
Sri Lanka
China
Africa
Oceania
Japan
Vietnam
Belarus
Chile
Belgium
Hong Kong
Finland
Ghana
Georgia
Ethiopia
Gibraltar
Faroe Islands
Denmark
Egypt
Estonia
Costa Rica
Hungary
Greece
Barbados
Croatia
Belize
Bahrain
Czech Republic
Algeria
Ecuador
Bulgaria
Bermuda
France
Kuwait
Malta
Morocco
Nicaragua
Mali
Lithuania
Peru
Lebanon
Jersey
Norway
Myanmar
Mauritius
Liberia
Mexico
Malaysia
Liechtenstein
Philippines
Italy
Israel
Panama
Poland
Senegal
Dominican Republic
Nigeria
Iraq
Azerbaijan
Bahamas
Iceland
Namibia
United Arab Emirates
Jamaica
Honduras
Bolivia
Isle of Man
Luxembourg
Albania
Pakistan
Grenada
Jordan
Bangladesh
Argentina
Romania
Sierra Leone
Tunisia
Kazakhstan
Kenya
Cayman Islands
Cambodia
Togo
Serbia
Turkey
Latvia
Cyprus
Oman
San Marino
Thailand
Uzbekistan
Taiwan
Sweden
Tanzania
Slovenia
El Salvador
Portugal
Tajikistan
Ukraine
Puerto Rico
Uganda
Venezuela
Uruguay
Zambia
Zimbabwe
Rwanda
Russian Federation
Cameroon
Austria
Switzerland
Colombia
Guatemala
Seychelles
Marshall Islands
VC (Venture Capital) Funds in Hong Kong by industry
Social
Financial Services
Big Data
Cryptocurrency
Education
Finance
Payments
Food and Beverage
Organic Food
Medical
Wellness
Internet
Social Media
Manufacturing
Art
Digital Media
Music
Mobile
Blockchain
Construction
Sports
eSports
Travel
Hospitality
InsurTech
Biotechnology
Recruiting
FinTech
Enterprise
Health Care
EdTech
Biotech
Climate
Energy
Sustainability
Android
Artificial intelligence
Proptech
Marketplace
Community
Hardware
Gaming
Real Estate
Web3
Mobile Apps
Retail
Fashion
B2B
Enterprise Software
Consumer
Transportation
Renewable Energy
Machine Learning
Life Science
Software
Video Games
Clean Energy
Fitness
Automotive
Agriculture (agtech)
Platforms
Media (entertainment)
SaaS
Impact